Message from Norman Rosenblum, INMD Scientific Director
January 2023

With the start of the new year, I am very pleased to announce new additions to the INMD Institute Advisory Board (IAB): Dr. Eric Benchimol, from the SickKids Research Institute and University of Toronto, Dr. Lakshman Gunaratnam, from Western University, and Dr. Erin Mulvihill from the University of Ottawa.  Each of these researchers will bring a wealth of experience and the perspectives from their respective research communities, to the IAB.  Please visit the INMD website to read more about these new INMD IAB members.

I would also like to encourage you to share your opinions by completing a survey about the Monthly INMD newsletter.  We will use the survey information we collect to improve the newsletter format and content.

Wishing you all a very healthy, happy and productive 2023!

Eric Benchimol, MD, PhD, FRCPC, NASPGHAN-F

Northbridge Financial Corporation Chair in Inflammatory Bowel Disease, SickKids Inflammatory Bowel Disease Centre, The Hospital for Sick Children
Professor, Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto
Senior Scientist, Child Health Evaluative Sciences, SickKids Research Institute
Senior Core Scientist, ICES

Erin Mulvihill, PhD

Associate Professor, Department of Biochemistry, Microbiology and Immunology, University of Ottawa
Director and Scientist, University of Ottawa Heart Institute

Lakshman Gunaratnam, MD, PhD

Associate Professor and Clinician-Scientist, Department of Medicine and Microbiology & Immunology, University of Western Ontario

Norman Rosenblum, MD, FRCPC, FCAHS
Scientific Director
Institute of Nutrition, Metabolism and Diabetes

Date modified:

2023-01-24